These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 498157)

  • 21. Ovarian metastases from carcinoma of the bilharzial urinary bladder.
    Soliman OM; el-Bolkainy N; Mansour A; Sherif M
    Int Surg; 1976; 61(6-7):364-5. PubMed ID: 939668
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Carcinoma of the bilharzial bladder.
    Hanash KA
    Prog Clin Biol Res; 1984; 162B():249-74. PubMed ID: 6390447
    [No Abstract]   [Full Text] [Related]  

  • 23. A case of liver toxicity following cis-dichlorodiammineplatinum(II) treatment.
    Cavalli F; Tschopp L; Sonntag RW; Zimmermann A
    Cancer Treat Rep; 1978 Dec; 62(12):2125-6. PubMed ID: 751721
    [No Abstract]   [Full Text] [Related]  

  • 24. [Ototoxicity of cis-diammine glycolato platinum, 254-S].
    Horiuchi M; Miyake H; Ota K
    Gan To Kagaku Ryoho; 1992 Aug; 19(9):1327-32. PubMed ID: 1503488
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Peripheral neuropathy associated with cis-dichlorodiammineplatinum (II) treatment.
    Hadley D; Herr HW
    Cancer; 1979 Dec; 44(6):2026-8. PubMed ID: 228833
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The NCI-Canada trial of concurrent cisplatin and radiotherapy for muscle invasive bladder cancer.
    Coppin C; Gospodarowicz M
    Prog Clin Biol Res; 1990; 353():75-83. PubMed ID: 2217429
    [No Abstract]   [Full Text] [Related]  

  • 27. Metastatic cloacogenic carcinoma of the anus: sequential responses to adriamycin and cis-dichlorodiammineplatinum(II).
    Fisher WB; Herbst KD; Sims JE; Critchfield CF
    Cancer Treat Rep; 1978 Jan; 62(1):91-7. PubMed ID: 627000
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Phase II study of cis-dichlorodiammineplatinum (II) in non-Hodgkin's lymphoma].
    Onoshi T; Hayashi K; Ueoka H; Nishihara R; Toyota K
    Gan To Kagaku Ryoho; 1984 Apr; 11(4):954-5. PubMed ID: 6539097
    [No Abstract]   [Full Text] [Related]  

  • 29. A comprehensive protocol for management of cancer of the bilharzial bladder.
    Sherif M
    Urol Res; 1978; 6(4):237-9. PubMed ID: 105442
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phase II trial of cyclophosphamide, doxorubicin, and cisplatin (CAP) versus amsacrine in patients with transitional cell carcinoma of the urinary bladder: a Southwest Oncology Group study.
    Al-Sarraf M; Frank J; Smith JA; O'Bryan RM; Costanzi JJ; Stephens RL; Caraveo J; Crawford ED
    Cancer Treat Rep; 1985 Feb; 69(2):189-94. PubMed ID: 2578880
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Phase II study of cis-diamminedichloroplatinum (II) in genitourinary cancer].
    Gan To Kagaku Ryoho; 1982 Mar; 9(3):433-42. PubMed ID: 6764107
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pathology of bilharzial bladder cancer.
    Godwin JT; Hanash K
    Prog Clin Biol Res; 1984; 162A():95-143. PubMed ID: 6483922
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Urinary lactic dehydrogenase activity as a diagnostic test for detection of bilharzial bladder cancer.
    Wassef SA; Abdel Sayed W; Mohran Y; Bassily S; Abdel Ghaffar Y
    J Egypt Med Assoc; 1969 Apr; 52(4):274-83. PubMed ID: 5397618
    [No Abstract]   [Full Text] [Related]  

  • 34. Phase II trial of amsacrine (AMSA) in urinary bladder cancer.
    Natale RB; Yagoda A; Blumenreich MS; Watson RC
    Cancer Treat Rep; 1983 Apr; 67(4):391-2. PubMed ID: 6687836
    [No Abstract]   [Full Text] [Related]  

  • 35. Chromosomal aberrations in Cis and Ta bilharzial bladder cancer: a theory of pathogenesis.
    Khaled HM; Aly MS; Mokhtar N
    Urol Oncol; 2004; 22(6):443-7. PubMed ID: 15610858
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Systemic chemotherapy in the management of advanced bladder cancer.
    Hall RR
    Arch Esp Urol; 1990; 43 Suppl 2():193-6. PubMed ID: 2096778
    [No Abstract]   [Full Text] [Related]  

  • 37. [Fundamental studies on intravesical instillation of cis-diamminedichloroplatinum for treatment of urinary bladder tumors. II. On the effects of intravesical instillation of cis-diamminedichloroplatinum in bladder cancer patients].
    Hirao Y; Iwai A; Moriya A; Matsuki H; Yoshida Y; Komada S; Sasaki K; Kubota K; Sanma S; Babaya K
    Hinyokika Kiyo; 1985 Sep; 31(9):1565-73. PubMed ID: 4083214
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Adjuvant topical chemotherapy with cisplatin in superficial bladder cancer].
    Flamm J; Grof F
    Urologe A; 1986 Jan; 25(1):48-50. PubMed ID: 3962044
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Cis-radiation therapy of locally advanced bladder cancer].
    Itatani H; Utsunomiya M
    Gan To Kagaku Ryoho; 1989 Sep; 16(9):3129-35. PubMed ID: 2782911
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Urinary nitrate, nitrite and N-nitroso compounds in bladder cancer patients with schistosomiasis (bilharzia).
    Tricker AR; Mostafa MH; Spiegelhalder B; Preussmann R
    IARC Sci Publ; 1991; (105):178-81. PubMed ID: 1855845
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.